Related Experiment Video
Updated: Aug 11, 2026
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Dosimetric analysis of orthogonal collimator configuration in volumetric modulated arc therapy planning: a
Xin Huang1,2, Chenlei Guo3, Shuangtong Liu1,2
1Department of Oncology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China.
Background:
In volumetric modulated arc therapy (VMAT), collimator angle selection impacts dose distribution and plan quality. Conventional VMAT plans use dual arcs with collimators set at 0˚. This study explores the dosimetric effects of using orthogonal collimator angles (0˚ and 90˚) in dual-arc VMAT.
Methods:
Sixty patients with head and neck, thoracic, and abdominal tumors were analyzed. Two VMAT plans were generated: Plan A (0˚ collimator angle) and Plan B (0˚ and 90˚ collimator angles). Dosimetric endpoints included conformity index (CI), gradient measure (GM), homogeneity index (HI), dose to organs at risk (OARs), mean dose to normal tissues (Dmean, NT), monitor units (MU), and gamma pass rate (GPR).
Results:
Plan B improved dosimetric outcomes over Plan A. HI decreased by 0.03 in the rectum, 0.01 in the breast, and 0.01 in the larynx. GM decreased by 0.15 cm in the rectum, 0.05 cm in the breast, and 0.01 cm in the larynx. OAR doses were reduced across sites, with notable decreases in the bladder (-4.62 Gy), left anterior descending artery (-3.99 Gy), and spinal cord (-1.79 Gy). Dmean,NT was slightly reduced in the rectum, breast and larynx. MU increased in rectum plans (+41 MU), but decreased in the breast and laryngeal plans by 38 MU and approximately 73 MU, respectively. All plans achieved GPR > 95%.
Conclusion:
Incorporating orthogonal collimator angles (0˚ and 90˚) in dual-arc VMAT enhances dose conformity and spares OARs without compromising target coverage or delivery accuracy. This approach is clinically applicable with minimal workflow changes.
